AIM at Melanoma Earns a Four-Star Rating From Charity Navigator
December 21, 2022 (Richmond, California) AIM at Melanoma is proud to announce that its strong financial health and ongoing accountability…
Philanthropy
12/23/2022
AIM at Melanoma Earns a Four-Star Rating From Charity Navigator
December 21, 2022 (Richmond, California) AIM at Melanoma is proud to announce that its strong financial health and ongoing accountability…
|
11/16/2022
How’s it Growing?
AIM at Melanoma is honored to have been selected by the Matthew Hill Foundation to be a benefitting charity in…
|
11/16/2022
The Importance of Having a Will
It started with a 13-year melanoma survivor letting us know that he had put us in his will. Jeff Berg,…
|
10/25/2022
Things Are About To Get Hairy!
As the name suggests, No-Shave November is an annual event during which participants forgo shaving and other hair trimming in…
10/12/2022
Create a Legacy with AIM
October 17th – 23rd, 2022 is National Estate Planning Awareness Week Creating a legacy gift that supports melanoma research in…
|
03/21/2022
Life After Loss: Lisa Huntley’s Life Has Come Full Circle
by Mara Klecker Lisa Huntley remembers walking out of the hospital without her husband, Grant, in 1994 and thinking to…
|
|
01/26/2022
Become a Member of the Supporters Guild
“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
|
01/26/2022
Walking to Conquer Melanoma: Mike’s Miracle Workers
By Mara Klecker Even when the pandemic forced the KDB Melanoma 5k Walk/Run to go virtual in 2020, Mike’s Miracle…
|
|
12/09/2021
A Heartfelt Thank You To Our Auction Sponsors
Thank you, thank you, thank you to the donors for our 2021 online auction! The Gratitude Gala—AIM at Melanoma’s…
|
12/07/2021
In One Woman’s Memory, a Tradition Helps Create a Community of Support
by Mara Klecker The idea for a walk to raise funds and awareness for melanoma came to Tricia Edwards…
|
|
Recent Posts
Sep. 15, 2024
Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab
Sep. 15, 2024
Ten Years of Pembrolizumab Shows Sustained Results
Sep. 15, 2024
Oncolytic Virotherapy Shows Promise in Advanced Melanoma that Failed Immunotherapy
Sep. 15, 2024
New Therapies Under Investigation for Patients With Metastatic Uveal Melanoma
Sep. 14, 2024